- Home
- SMBK vs LENZ Comparison
SMBK vs LENZ Comparison
Compare SMBK & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMBK
- LENZ
- Stock Information
- Founded
- SMBK N/A
- LENZ 2019
- Country
- SMBK United States
- LENZ United States
- Employees
- SMBK N/A
- LENZ N/A
- Industry
- SMBK Major Banks
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- SMBK Finance
- LENZ Health Care
- Exchange
- SMBK Nasdaq
- LENZ Nasdaq
- Market Cap
- SMBK 580.6M
- LENZ 679.4M
- IPO Year
- SMBK N/A
- LENZ 2021
- Fundamental
- Price
- SMBK $31.06
- LENZ $24.75
- Analyst Decision
- SMBK Buy
- LENZ Strong Buy
- Analyst Count
- SMBK 6
- LENZ 6
- Target Price
- SMBK $30.50
- LENZ $35.40
- AVG Volume (30 Days)
- SMBK 44.3K
- LENZ 150.7K
- Earning Date
- SMBK 04-21-2025
- LENZ 03-19-2025
- Dividend Yield
- SMBK 1.03%
- LENZ 58.15%
- EPS Growth
- SMBK 26.63
- LENZ N/A
- EPS
- SMBK 2.14
- LENZ N/A
- Revenue
- SMBK $166,349,000.00
- LENZ N/A
- Revenue This Year
- SMBK $19.44
- LENZ N/A
- Revenue Next Year
- SMBK $9.83
- LENZ N/A
- P/E Ratio
- SMBK $14.49
- LENZ N/A
- Revenue Growth
- SMBK 11.36
- LENZ N/A
- 52 Week Low
- SMBK $19.00
- LENZ $2.57
- 52 Week High
- SMBK $37.72
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- SMBK 27.57
- LENZ 55.66
- Support Level
- SMBK $30.69
- LENZ $21.98
- Resistance Level
- SMBK $31.56
- LENZ $23.92
- Average True Range (ATR)
- SMBK 0.88
- LENZ 1.42
- MACD
- SMBK -0.45
- LENZ 0.37
- Stochastic Oscillator
- SMBK 8.43
- LENZ 84.27
About SMBK SmartFinancial Inc.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.